Rh(D) haemolytic disease of the newborn: the changing scene.
- 6 July 1985
- Vol. 291 (6487) , 4-6
- https://doi.org/10.1136/bmj.291.6487.4
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Prediction of the Outcome of Rhesus Haemolytic Disease of the Newborn: Additional Information Using an ADCC AssayVox Sanguinis, 1984
- ANTENATAL ANTI-D IMMUNOGLOBULINThe Lancet, 1983
- THE YORKSHIRE ANTENATAL ANTI-D IMMUNOGLOBULIN TRIAL IN PRIMIGRAVIDAEThe Lancet, 1983
- MORTALITY IN THERAPEUTIC HAEMAPHERESISThe Lancet, 1983
- Fetal blood group studies during mid‐trimester pregnancy and the management of severe isoimmunizationPrenatal Diagnosis, 1983
- Maternal anti-D concentrations and outcome in rhesus haemolytic disease of the newborn.BMJ, 1982
- A CASE FOR THE ANTENATAL ADMINISTRATION OF ANTI-D IMMUNOGLOBULIN TO PRIMIGRAVIDAEThe Lancet, 1981
- SHOULD ANTI-D IMMUNOGLOBULIN BE GIVEN ANTENATALLY?The Lancet, 1980
- Prevention of Rh haemolytic disease.BMJ, 1978
- Continuous-flow plasmapheresis in management of severe rhesus disease.BMJ, 1977